US Edition
AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
UNITED STATES, JUL 21 – AstraZeneca plans to create tens of thousands of skilled jobs and leverage AI and automation to expand manufacturing and R&D, aiming for $80 billion in annual revenue by 2030.
- On July 21, 2025, AstraZeneca announced plans to invest $50 billion by 2030 to expand manufacturing and research in the U.S., including a new Virginia facility.
- This large investment follows sustained U.S. tariffs and political pressure from President Trump urging pharmaceutical companies to increase domestic production, as explained by Commerce Secretary Howard Lutnick.
- The Virginia facility will be AstraZeneca's largest manufacturing investment worldwide, producing active ingredients for weight management and cholesterol medicines, while expansions will cover five other U.S. states.
- AstraZeneca CEO Pascal Soriot stated that the funding initiative aligns with the company’s target to generate $80 billion in yearly sales by 2030, with approximately 50% expected to originate from the U.S. Meanwhile, Commerce Secretary Howard Lutnick described the investment as a landmark move that will create tens of thousands of employment opportunities.
- The investment signals AstraZeneca's prioritization of the U.S. market, reacting to tariff policies and industry pressures, and follows similar commitments by other top drugmakers to boost domestic manufacturing and R&D.
190 Articles
190 Articles
AstraZeneca manufacturing facility coming to Virginia
RICHMOND, Va. (WRIC) -- AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia. According to an announcement by the company on Monday, July 21, AstraZeneca plans to build a multi-billion-dollar manufacturing facility to make drugs used for weight management and metabolic health, including oral GLP-1, baxdrosat, oral PCSK9 and other products. The facility is planned to be locate…
Headlines from across the state: AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs; more …
Here are some of the top headlines from other news outlets around Virginia. Some content may be behind a metered paywall: Economy: AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs. — Virginia Mercury. Frontier plans Richmond flights to Atlanta, Denver. — Richmond Times-Dispatch (paywall). Politics: Lawsuit over Virginia’s felon voting ban gains steam with new legal filings. — Virginia Mercury. E…
The British pharmaceutical company AstraZeneca announced that it plans to invest $50 billion by 2030 in the manufacture and development of medicines in the United States, whose President Donald Trump weighs tariffs on the sector. This investment “strengthens our confidence in US innovation in biopharmaceutical products and our commitment to the millions of patients who need drugs in the United States and around the world,” said the company’s CEO…
Pharmaceutical giant to build its largest manufacturing facility in Va., creating hundreds of jobs
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to build its largest drug manufacturing facility in the world somewhere in the commonwealth — marking the company’s single biggest investment ever.
Huge: Astra Zeneca's $50 Billion Investment in the USA, Their Largest in the World
As President Trump welcomed Philippine President Ferdinand Marcos Jr. in the White House today, he announced Astra Zeneca's $50 billion investment in the United States. We can undoubtedly thank Trump's tariffs in part. President Trump is bringing manufacturing back to the States. It's
AstraZeneca investing $50B in US, Trump calls it an ‘honor’
British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and President Trump calling it an “honor.” The company announced the investment on Monday, saying it would invest $50 billion into the country by 2030 to build on “America’s…
Coverage Details
Bias Distribution
- 47% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
